Amphastar Pharmaceuticals, Inc.
AMPH
$27.10
-$0.48-1.74%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
12/4/2025
-
MarketBeat
12/3/2025
-
StockStory Articles
11/30/2025
-
Simply Wall St
11/29/2025
-
Simply Wall St
11/27/2025
-
Simply Wall St
11/27/2025
-
Ticker Report
11/27/2025
-
MarketBeat
11/27/2025
-
MarketBeat
11/26/2025
-
MarketBeat
11/24/2025
-
GuruFocus
11/24/2025
-
GuruFocus
11/24/2025
-
ACCESS Newswire
11/21/2025
-
StockStory Articles
11/20/2025
-
StockStory Articles
11/19/2025
-
SeekingAlpha
11/18/2025
-
MarketBeat
11/18/2025
-
MarketBeat
11/18/2025
-
StockStory Articles
Amphastar Pharmaceuticals (AMPH, $26.37) RSI Indicator left the overbought zone on November 13, 2025
11/14/2025
-
Tickeron - Stocks
11/13/2025
-
Simply Wall St
Amphastar Pharmaceuticals (AMPH, $27.83) RSI Indicator left the overbought zone on November 12, 2025
11/13/2025
-
Tickeron - Stocks
11/13/2025
-
StockStory Articles
11/13/2025
-
StockStory Articles
11/12/2025
-
StockStory Articles
11/12/2025
-
GuruFocus
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, November 6, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Mar 2 and 6 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
909 980 9484
Address
11570 6th Street
Rancho Cucamonga, CA 91730
Rancho Cucamonga, CA 91730
Country
Year Founded
Business Description
Sector
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United...
more